Over-the-Counter Pain Medication

Over-the-Counter Pain Medication Market Outlook

The global Over-the-Counter (OTC) pain medication market is projected to reach approximately USD 52 billion by 2035, growing at a CAGR of around 5.2% from 2025 to 2035. The increasing prevalence of chronic pain conditions, coupled with a growing aging population, is significantly driving the demand for OTC pain relief products. Additionally, the rising awareness regarding self-medication and the convenience of purchasing these medications without a prescription are further propelling market growth. The shift towards non-invasive pain management solutions, particularly among consumers seeking alternatives to prescription medications, is also contributing to the expansion of the market. Overall, the combination of these factors points towards a robust growth trajectory for the OTC pain medication market in the coming years.

Growth Factor of the Market

One of the primary growth factors for the OTC pain medication market is the increasing prevalence of lifestyle diseases and chronic conditions, such as arthritis and back pain, that necessitate effective pain management solutions. As the global population ages, the demand for pain relief products is set to surge, with older adults often experiencing higher incidences of chronic pain. Furthermore, the convenience and accessibility of OTC medications compared to prescription options are appealing to consumers, driving a notable shift towards self-medication. Pharmacists and healthcare providers are increasingly recommending OTC solutions for mild to moderate pain relief, which further supports market growth. The COVID-19 pandemic has also highlighted the importance of self-care, prompting more individuals to seek OTC pain management options as they prioritize health and wellness at home.

Key Highlights of the Market

• Significant growth expected due to an aging population and increasing chronic pain prevalence.
• Rising consumer preference for self-medication and over-the-counter products.
• Innovations in product formulations that enhance efficacy and safety.
• Increased availability of OTC products through diverse distribution channels.
• Growing awareness and education regarding pain management options among consumers.

By Product Type

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) :

Nonsteroidal anti-inflammatory drugs (NSAIDs) represent a significant segment of the OTC pain medication market, primarily due to their effectiveness in managing pain and inflammation. Common NSAIDs such as ibuprofen and naproxen are widely used for conditions like headaches, arthritis, and muscle pain. The availability of these medications in various forms, including tablets, liquids, and topical patches, caters to a diverse consumer base. With growing consumer awareness regarding the importance of pain management, the demand for NSAIDs is increasing, supported by ongoing marketing efforts highlighting their benefits. Additionally, the introduction of NSAIDs with fewer gastrointestinal side effects is likely to further boost their market share, as patients seek effective pain relief without compromising their digestive health.

Acetaminophen :

Acetaminophen is another crucial component of the OTC pain medication market, known for its analgesic and antipyretic properties. It is widely recommended for the relief of mild to moderate pain, such as headaches, toothaches, and fevers. Its relatively low risk of side effects compared to NSAIDs makes it a popular choice, especially among individuals who may be sensitive to the latter's gastrointestinal effects. As healthcare professionals increasingly recommend acetaminophen for pain management, the product continues to enjoy strong market penetration. Manufacturers are also exploring innovative formulations to enhance product effectiveness and user experience, further solidifying acetaminophen’s position in the OTC pain medication landscape.

Aspirin :

Aspirin, a classic analgesic and anti-inflammatory medication, remains a significant player in the OTC pain medication market. Known for its efficacy in relieving pain from various conditions, including headaches and muscle aches, aspirin also possesses cardioprotective properties, making it popular among older adults. Despite facing competition from newer pain relief options, aspirin's affordability and established efficacy ensure its continued relevance in the market. Furthermore, ongoing research into additional health benefits associated with aspirin use may drive renewed interest and consumption among consumers, particularly in preventive health scenarios.

Topical Analgesics :

Topical analgesics are gaining traction in the OTC pain medication market, offering localized relief through creams, gels, and patches applied directly to the skin. These products can be particularly appealing to individuals seeking non-invasive pain management solutions, especially for conditions such as joint pain and muscle soreness. The growth in this segment is supported by increasing consumer awareness regarding the efficacy of topical treatments and the preference for alternatives to oral medications. As manufacturers innovate to develop fast-acting and long-lasting topical formulations, the market for topical analgesics is poised for significant expansion.

Combination Products :

Combination products that blend two or more active ingredients to target multiple symptoms are also experiencing growth within the OTC pain medication market. These products typically combine analgesics with other medication types, such as antihistamines or decongestants, providing comprehensive relief for conditions like colds or allergies. The convenience of using a single product for multifaceted relief appeals to consumers looking for efficiency in their healthcare choices. As the demand for multifunctional medications continues to rise, manufacturers are likely to explore novel combinations that enhance therapeutic effectiveness, thereby further capturing market share in this segment.

By Inflammatory Drugs

Ibuprofen :

Ibuprofen, an NSAID, is one of the most widely used over-the-counter pain medications, primarily due to its efficacy in relieving pain and inflammation. It is particularly effective for treating headaches, dental pain, menstrual cramps, and arthritis-related discomfort. The ability to reduce fever further broadens its appeal to consumers. As healthcare professionals increasingly endorse ibuprofen for various pain management scenarios, market demand remains strong. Additionally, innovative formulations, such as liquid gels and effervescent tablets, are enhancing consumer convenience and adherence to treatment regimens, positively impacting ibuprofen's market presence.

Acetaminophen :

Acetaminophen is a widely recognized medication for pain relief and fever reduction, offering a versatile option for consumers experiencing mild to moderate pain. Its safety profile, particularly for individuals who may be contraindicated for NSAIDs, reinforces acetaminophen's position as a staple in OTC pain relief. As more consumers gravitate towards safer alternatives for pain management, acetaminophen's market share is expected to grow. Manufacturers continue to innovate by developing formulations that improve absorption and efficacy, ensuring that acetaminophen remains a top choice for consumers seeking effective relief without the adverse effects associated with other pain medications.

Naproxen :

Naproxen, another popular NSAID, is recognized for its long-lasting pain relief properties. It is particularly effective for treating conditions like arthritis and chronic musculoskeletal pain, leading to its growing popularity among consumers with recurring pain issues. The once-daily dosing regimen appeals to those seeking sustained relief without frequent administration, enhancing patient compliance. As awareness of naproxen's benefits continues to spread, the market for this medication is poised for growth, especially with ongoing research further substantiating its safety and efficacy profile.

Diclofenac :

Diclofenac is an established NSAID used for pain management, particularly in patients with inflammatory conditions. It is available in topical formulations, which are particularly appealing for localized pain relief without systemic side effects. As consumer preferences shift towards non-invasive treatment options, topical diclofenac products are witnessing increased adoption. The dual effectiveness of diclofenac in managing pain and inflammation makes it a preferred choice for many patients. Continuous research and development efforts aimed at improving diclofenac formulations will likely drive sustained growth in this market segment.

Ketoprofen :

Ketoprofen is a lesser-known NSAID but is gaining traction in the OTC pain medication market due to its potent analgesic properties. It is effective in managing pain associated with various conditions, including arthritis and muscular pain. Ketoprofen is commonly available in both oral and topical formulations, providing options for consumers based on their preferences. As research continues to validate its efficacy and safety, ketoprofen is expected to gain visibility in the market, particularly among consumers seeking effective yet less commonly discussed pain relief options.

By Application

Pain Management :

Pain management constitutes the primary application of OTC pain medication, encompassing a wide range of conditions, including headaches, muscle aches, and chronic pain disorders. The escalating prevalence of chronic pain conditions, such as arthritis and fibromyalgia, is significantly contributing to the growth of this segment. Patients increasingly seek effective pain relief solutions without the need for prescriptions, leading to higher sales of OTC medications. Awareness campaigns promoting self-management of pain and the benefits of utilizing OTC products are further bolstering this application segment, driving demand and facilitating market growth.

Fever Management :

Fever management is another critical application area for OTC pain medications, with acetaminophen and ibuprofen being the most commonly used products in this category. Especially during seasonal outbreaks of flu and viruses, the demand for fever-reducing medications tends to spike significantly. The growing awareness regarding the importance of promptly managing fever symptoms, particularly in children, has led to an increasing preference for OTC medications as safe and effective options. Furthermore, educational initiatives surrounding the proper use of these medications for fever management are enhancing consumer confidence and driving market growth.

By Distribution Channel

Pharmacies :

Pharmacies have long been the traditional distribution channel for OTC pain medications, providing consumers with immediate access to a range of products. The trust consumers place in pharmacies, alongside the ability to consult with pharmacists regarding appropriate medication options, enhances the effectiveness of this channel. The increasing number of pharmacies globally, alongside the expansion of pharmacy chains, is facilitating greater accessibility to OTC pain medications. Additionally, promotional activities, such as discounts and loyalty programs, further attract consumers to pharmacies, ensuring their continued relevance in the OTC pain medication landscape.

Drug Stores :

Drug stores serve as vital distribution outlets for OTC pain medications, offering a wide range of products that cater to diverse consumer needs. With their emphasis on health and wellness, drug stores provide an environment where consumers can find pain relief solutions alongside other health products. The convenience of shopping for OTC medications in drug stores, combined with the ability to consult staff for recommendations, enhances the consumer experience. As the number of drug stores continues to grow and evolve, they remain essential players in the distribution of OTC pain medications.

Online Retail :

The online retail segment for OTC pain medications has gained significant momentum in recent years, driven by the convenience and ease of shopping from home. Consumers are increasingly turning to e-commerce platforms to purchase pain relief products, especially amid circumstances where in-person visits to pharmacies may be limited. The rise of e-commerce giants, along with the proliferation of specialized health websites, has made it easier for consumers to access a broader range of OTC pain medications. Furthermore, the availability of customer reviews and product comparisons online provides consumers with the information needed to make informed purchasing decisions, contributing to the growth of this channel.

By Ingredient Type

Ibuprofen :

Ibuprofen remains one of the most recognized ingredient types in the OTC pain medication landscape, appreciated for its dual capacity to alleviate both pain and inflammation. As a widely effective NSAID, it is commonly used for various conditions such as headaches, dental pain, and menstrual cramps. Its favorable safety profile, particularly when compared to other NSAIDs, has made ibuprofen a go-to choice for consumers seeking relief. The development of diverse formulations, including liquid gels and dissolvable tablets, enhances the appeal of ibuprofen, allowing consumers to choose options that align with their personal healthcare preferences and needs.

Acetaminophen :

Acetaminophen is a cornerstone ingredient in the OTC pain medication market, valued for its effectiveness in managing mild to moderate pain and reducing fever. Its unique mechanism of action, which differs from that of NSAIDs, makes it suitable for individuals who may be sensitive to anti-inflammatory medications. The widespread availability of acetaminophen in various formulations, including children's liquid formulations and combination products, increases its accessibility to different consumer demographics. Ongoing research into acetaminophen's effectiveness and safety continues to support its central role in pain management, solidifying its position in the market.

Naproxen :

Naproxen is recognized for its extended pain relief capabilities, making it a preferred option for individuals suffering from chronic conditions such as arthritis. As an NSAID, it effectively addresses pain and inflammation, offering patients the convenience of less frequent dosing. The growing awareness of its efficacy, particularly for long-term pain management, is driving its adoption among consumers. The availability of naproxen in various formulations enhances its market penetration, catering to diverse consumer preferences and bolstering its status in the OTC pain medication sector.

Diclofenac :

Diclofenac, a well-established NSAID, is primarily utilized in the OTC pain medication market for its capability to manage pain and inflammation effectively. Unique formulations featuring diclofenac, particularly topical options, have gained popularity among consumers seeking localized pain relief without systemic side effects. The growing emphasis on non-invasive treatment options for pain management is likely to drive increased adoption of diclofenac products. Ongoing research into its effectiveness and safety ensures that diclofenac will remain a significant ingredient type in the OTC pain medication market.

Ketoprofen :

Ketoprofen is an important ingredient in the OTC pain medication market, recognized for its powerful analgesic effects in treating various pain conditions. While it may not be as widely known as other NSAIDs, ketoprofen's effectiveness in managing pain, especially inflammatory pain, is gaining attention among healthcare professionals and consumers alike. The development of ketoprofen in both oral and topical formulations provides consumers with options tailored to their pain management needs. As consumer understanding of ketoprofen's benefits continues to grow, its acceptance in the market is likely to increase, contributing to its overall growth as an ingredient type.

By Region

The North American region holds a significant share of the global OTC pain medication market, driven by a combination of high consumer awareness, robust healthcare infrastructure, and a large aging population. The increasing prevalence of chronic pain conditions and a growing trend towards self-medication are propelling demand in the region. According to estimates, the North American OTC pain medication market is expected to exhibit a CAGR of about 5.5% over the forecast period, emphasizing the continued growth potential in this market. Moreover, the increasing penetration of e-commerce platforms has made these products more accessible to consumers, further boosting sales.

In Europe, the OTC pain medication market is also witnessing substantial growth, supported by a rising focus on health and wellness among consumers. The region benefits from a well-established pharmacy network that facilitates the easy availability of OTC pain relief products. Additionally, favorable regulatory frameworks regarding the sale of OTC medications are enhancing market accessibility. The European market is projected to grow at a CAGR of approximately 4.8% during the forecast period, indicating a healthy growth trajectory driven by increased consumer demand for pain management solutions.

Opportunities

The OTC pain medication market presents numerous opportunities for growth, particularly through the introduction of innovative formulations and delivery methods. As consumer preferences shift towards non-invasive treatment options, the development of topical analgesics that offer targeted relief is a key opportunity for manufacturers. Companies can explore novel ingredients or combinations that enhance the efficacy and safety of pain management products, catering to a growing consumer base that prioritizes wellness and self-care. Furthermore, the expansion of online retail channels presents significant opportunities for reaching a broader audience, particularly younger consumers who prefer shopping via e-commerce platforms. By establishing a strong online presence and leveraging digital marketing strategies, companies can increase brand visibility and drive sales.

Additionally, there is a growing demand for personalized medicine, creating opportunities for manufacturers to tailor OTC pain medications to specific consumer needs. This could involve developing products with varying dosages or specialized formulations targeted at specific demographics, such as children or elderly patients. The rising trend towards natural and herbal pain relief solutions also opens a pathway for companies to explore plant-based ingredients that appeal to health-conscious consumers. Overall, the convergence of these opportunities provides a rich landscape for innovation and growth within the OTC pain medication market.

Threats

The OTC pain medication market faces several threats, one of which is the increasing competition from prescription medications that offer more potent pain relief options. As healthcare providers continue to advocate for comprehensive pain management strategies, patients may gravitate towards stronger prescription alternatives, potentially impacting the sales of OTC products. Additionally, adverse publicity associated with certain pain medications, particularly regarding their potential side effects and long-term use, could deter consumers from using OTC options. Regulatory challenges and stringent safety guidelines imposed by health authorities may also limit the introduction of new products in the market, complicating the landscape for potential entrants.

Moreover, the proliferation of counterfeit drugs poses a significant threat to consumer safety and brand integrity within the OTC pain medication market. Counterfeit products can lead to ineffective treatment and adverse health outcomes, eroding consumer trust in legitimate pharmaceutical companies. As a result, companies must actively invest in measures to ensure product authenticity and educate consumers about the risks of purchasing medications from unverified sources. Addressing these threats proactively will be crucial for stakeholders to maintain a competitive edge and ensure sustainable growth.

Competitor Outlook

• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc
• Bayer AG
• Procter & Gamble Co.
• Sanofi S.A.
• Novartis AG
• APOTEX Inc.
• Reckitt Benckiser Group plc
• Haleon plc
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Amgen Inc.
• Sun Pharmaceutical Industries Ltd.
• Aceto Corporation

The competitive landscape of the OTC pain medication market is characterized by the presence of several key players that dominate the market through their diverse product portfolios and strong brand recognition. Companies like Pfizer and Johnson & Johnson lead the market by offering a broad spectrum of pain relief products, including well-known brands such as Advil and Tylenol, respectively. Their established market presence, combined with continuous investment in research and development, allows these companies to innovate and meet changing consumer demands effectively. The focus on strategic partnerships and collaborations further strengthens their market position, enabling them to capitalize on emerging trends while maintaining a competitive edge.

Bayer AG and GlaxoSmithKline are also significant competitors in the OTC pain medication landscape, known for their extensive product lines that address various pain management needs. Bayer's Aspirin brand and GSK's Panadol product line have established strong market penetration and consumer loyalty. These companies engage in comprehensive marketing strategies to boost brand awareness and customer engagement, ensuring they remain top-of-mind for consumers seeking pain relief solutions. As competition intensifies, these established players are likely to explore innovative marketing approaches to differentiate themselves and capture a larger market share.

Emerging players, such as Haleon plc and Reckitt Benckiser Group, are also making their mark in the OTC pain medication space, focusing on natural and holistic pain relief options. These companies are capitalizing on the growing trend towards health and wellness, offering products that appeal to health-conscious consumers seeking non-pharmaceutical alternatives. As consumer preferences shift, these emerging players may disrupt traditional market dynamics, prompting established companies to adapt their strategies and product offerings to remain competitive. The overall landscape is dynamic, with ongoing developments and competitive shifts shaping the future of the OTC pain medication market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Bayer AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Haleon plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 APOTEX Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 AbbVie Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Novartis AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Pfizer Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sanofi S.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Aceto Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Johnson & Johnson
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GlaxoSmithKline plc
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Procter & Gamble Co.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Reckitt Benckiser Group plc
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Sun Pharmaceutical Industries Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Over-the-Counter Pain Medication Market, By Application
    • 6.1.1 Pain Management
    • 6.1.2 Fever Management
  • 6.2 Over-the-Counter Pain Medication Market, By Product Type
    • 6.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 6.2.2 Acetaminophen
    • 6.2.3 Aspirin
    • 6.2.4 Topical Analgesics
    • 6.2.5 Combination Products
  • 6.3 Over-the-Counter Pain Medication Market, By Ingredient Type
    • 6.3.1 Ibuprofen
    • 6.3.2 Acetaminophen
    • 6.3.3 Naproxen
    • 6.3.4 Diclofenac
    • 6.3.5 Ketoprofen
  • 6.4 Over-the-Counter Pain Medication Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Drug Stores
    • 6.4.3 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Over-the-Counter Pain Medication Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Over-the-Counter Pain Medication market is categorized based on

By Product Type

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen
• Aspirin
• Topical Analgesics
• Combination Products

By Application

• Pain Management
• Fever Management

By Distribution Channel

• Pharmacies
• Drug Stores
• Online Retail

By Ingredient Type

• Ibuprofen
• Acetaminophen
• Naproxen
• Diclofenac
• Ketoprofen

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc
• Bayer AG
• Procter & Gamble Co.
• Sanofi S.A.
• Novartis AG
• APOTEX Inc.
• Reckitt Benckiser Group plc
• Haleon plc
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Amgen Inc.
• Sun Pharmaceutical Industries Ltd.
• Aceto Corporation